Showing results (171-180 of 184) with videos related to

Sort By:
Pageof 19
European Addiction Research|June 23, 2020
Attention Deficit/Hyperactivity Disorder and Global Severity Profiles in Treatment-Seeking Patients with Substance Use DisordersRomain Icick, Franz Moggi, Ortal Slobodin, et al.
Rheumatology (Oxford, England)|June 24, 2026
CAR-T as a salvage treatment in polyrefractory rheumatoid arthritisMerav Lidar, Paula David, Elad Jacoby, et al.
Nature|May 12, 2021
SARS-CoV-2 uses a multipronged strategy to impede host protein synthesisYaara Finkel, Avi Gluck, Aharon Nachshon, et al.
Rheumatology (Oxford, England)|February 17, 2019
Lysyl oxidase-a possible role in systemic sclerosis-associated pulmonary hypertension: a multicentre studyZahava Vadasz, Alexandra Balbir Gurman, Pierluigi Meroni, et al.
The International Journal of Social Psychiatry|June 13, 2025
Religiousness and self-control in patients with substance use disorder (SUD) and comorbid attention deficit/hyperactivity disorder (ADHD)Alex Ha Begeman, Arnt Schellekens, Wim van den Brink, et al.
Annals of the Rheumatic Diseases|October 13, 2019
Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritisUta Kiltz, Robert B M Landewé, Désirée van der Heijde, et al.
Journal of Attention Disorders|February 29, 2016
Persistence and Subtype Stability of ADHD Among Substance Use Disorder Treatment SeekersSharlene Kaye, Josep Antoni Ramos-Quiroga, Geurt van de Glind, et al.
Molecular & Cellular Proteomics : MCP|June 3, 2019
Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and PlasmaBracha Shraibman, Eilon Barnea, Dganit Melamed Kadosh, et al.
Molecular & Cellular Proteomics : MCP|August 4, 2018
Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and PlasmaBracha Shraibman, Eilon Barnea, Dganit Melamed Kadosh, et al.
Pageof 19